홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Cesium carbonate → 3-chloro-5-{[5-chloro-1-(1H-pyrazolo[3,4-b]pyridin-3-ylmethyl)-1H-benzimidazol-4-yl]oxy}benzonitrile dihydrochloride

HRID 505531
인쇄

반응식

HRID 505531 반응식
[Cl:1][C:2]1[CH:3]=[C:4]([CH:7]=[C:8]([O:10][C:11]2[C:19]3[N:18]=[CH:17][NH:16][C:15]=3[CH:14]=[CH:13][C:12]=2[Cl:20])[CH:9]=1)[C:5]#[N:6].Br[CH2:22][C:23]1[C:31]2[C:26](=[N:27][CH:28]=[CH:29][CH:30]=2)[N:25](C(OC(C)(C)C)=O)[N:24]=1.C(=O)([O-])[O-].[Cs+].[Cs+]>CN(C=O)C.O>[ClH:1].[ClH:1].[Cl:1][C:2]1[CH:3]=[C:4]([CH:7]=[C:8]([O:10][C:11]2[C:19]3[N:18]=[CH:17][N:16]([CH2:22][C:23]4[C:31]5[C:26](=[N:27][CH:28]=[CH:29][CH:30]=5)[NH:25][N:24]=4)[C:15]=3[CH:14]=[CH:13][C:12]=2[Cl:20])[CH:9]=1)[C:5]#[N:6]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 3

HCID 10796Cesium carbonateHCID 10828872tert-Butyl 3-(bromomethyl)-1H-pyrazolo[3,4-b]pyridine-1-carboxylateHCID 684255163-chloro-5-[(5-chloro-1H-benzimidazol-4-yl)oxy]benzonitrile

생성물 1

HCID 1784786843-chloro-5-{[5-chloro-1-(1H-pyrazolo[3,4-b]pyridin-3-ylmethyl)-1H-benzimidazol-4-yl]oxy}benzonitrile dihydrochloride

시약·촉매·용매 2

HCID 962
Water
용매
HCID 6228Dimethylformamide용매

실험 절차

To a suspension of 3-chloro-5-[(5-chloro-1H-benzimidazol-4-yl)oxy]benzonitrile (101 mg, 0.332 mmol) and tert-butyl 3-(bromomethyl)-1H-pyrazolo[3,4-b]pyridine-1-carboxylate (104 mg, 0.332 mmol) in DMF (1 mL) was added cesium carbonate (216 mg, 0.664 mmol) and the suspension was stirred at room temperature for 2.25 hours. This mixture was diluted with water (10 mL) and extracted with ethyl acetate (2×12 mL). The combined extracts were washed with water, dried over MgSO4, filtered and evaporated in vacuo. This residue was purified on silica gel (40 g) column eluting with 0-100% ethyl acetate/methylene chloride. The fractions corresponding to the desired Boc protected product were combined and the solvent removed in vacuo. This residue was redissolved in TFA (3 mL) and allowed to stand at room temperature for 10 minutes. The solvent was removed in vacuo and the residue was purified on silica gel (4 g) column eluting with 0-10% methanol/methylene chloride gradient. The pure fractions were combined, treated with 1N hydrochloric acid and the solvent removed in vacuo to provide title compound. 1H NMR (DMSO-d6): δ 13.7 (s, 1H), 8.58 (s, 1H), 8.52 (d, 1H, J=4.4 Hz), 8.16 (d, 1H, 8.0 Hz), 7.74 (dd, 1H, J=1.5 Hz), 7.63 (d, 1H, J=8.8 Hz), 7.47 (d, 1H, J=8.5 Hz), 7.39 (dd, 1H, J=1.5 Hz), 7.29 (dd, 1H, J=2 Hz), 7.19 (dd, 1H, J=4.5 and 8.1 Hz) and 5.92 (s, 2H) ppm. LRMS (M+1)=434.7

후처리

  1. extractionextracted with ethyl acetate (2×12 mL)
  2. washThe combined extracts were washed with water
  3. dry with materialdried over MgSO4
  4. filtrationfiltered
  5. customevaporated in vacuo
  6. customThis residue was purified on silica gel (40 g) column
  7. washeluting with 0-100% ethyl acetate/methylene chloride
  8. customthe solvent removed in vacuo
  9. dissolutionThis residue was redissolved in TFA (3 mL)
  10. waitto stand at room temperature for 10 minutes
  11. customThe solvent was removed in vacuo
  12. customthe residue was purified on silica gel (4 g) column
  13. washeluting with 0-10% methanol/methylene chloride gradient
  14. additiontreated with 1N hydrochloric acid
  15. customthe solvent removed in vacuo

출처 및 근거

ORD 기록
ord-2709b1361e2c49cc87e7fae41bf8924a
출처 데이터셋
uspto-grants-2010_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07781454B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트